BGOG-EN-5

An Investigator-Sponsored Randomized Phase III Trial of Maintenance with Selinexor/ Placebo After Combination Chemotherapy for Patients with Advanced or Recurrent Endometrial Cancer 

EUDRA-CT number: 2017-000607-25

 

Study sites:

  • UZ Leuven, Leuven
  • Jan Yperman ziekenhuis, Ieper
  • AZ Turnhout, Turnhout
  • CHU Ambroise Paré, Mons